Clinical Trial

GRAM NEGATIVES STUDY

Study acronym: MR-GEIPC
Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, observational, multicenter study whose main objective is to develop a predictive model of mortality in critically ill patients colonized by multidrug-resistant Gram-negative bacteria (MDR-GNB). Secondary objectives include: determining the characteristics of patients colonized by MRGB who require admission or acquire colonization during their stay in an intensive care unit (ICU); studying the infectious complications they develop, their etiology, clinical impact, and prognosis.
Trial Details
NCT Number NCT07749508
Lead Sponsor Fundacion SEIMC-GESIDA
Conditions Multi-resistant Gram-negative Bacteria Cause Infection
Enrollment 1,500 participants
Start Date 2026-03-02
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-06